MedPath

Effect of Aliskiren on Endothelial Function in Hypertensive Patients with Ischemic Heart Disease

Not Applicable
Conditions
Hypertension Ischemic Heart Disease
Registration Number
JPRN-UMIN000007158
Lead Sponsor
niversity of Tokyo
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1)the history of allergy against aliskiren 2)diabetes HbA1C 6.5%< 3)unstabel angina, recent myocardial infaction or recent cerebral infarction (within 3 months) 4)severe liver dysfunction AST(GOT) or ALT(GPT) : 100U < 5)severe renal dysfunction Cre : 2.0< 6)pregnant 7)hyperkalemia 8) the history of drug and alcohol abuse

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath